Shares in the UK's IP Group slid today after it revealed that an arthritis drug in development at one of its portfolio ...

AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

Rheumatoid arthritis (RA) is an autoimmune disorder affecting millions worldwide, causing chronic inflammation, debilitating pain, and irreversible joint damage.

AnaptysBio may have ended last year on a low, but 2025 is looking up with the news that its PD-1 agonist rosnilimab has ...

This article helps to dispel myths related to rheumatoid arthritis (RA) and raise awareness regarding it. From causes to ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA ... concomitant medications and illnesses, dates of studies performed ...

test and develop a series of drug candidates for a number of diseases, including rheumatoid arthritis, heart disease and several neurodegenerative disorders. Derek R. Duckett, associate scientific ...

Steroids are powerful anti-inflammatory drugs that can treat many forms of arthritis, including rheumatoid arthritis, lupus, and other forms of inflammation such as vasculitis. Although effective ...

A new Swedish study has, for the first time, shown a link between rheumatoid arthritis (RA ... excess synovial fluid, and the development of fibrous tissue (pannus) in the synovium.

Biologics represent a class of medications in which we can target ... the treatment towards getting a particular person's rheumatoid arthritis under better control. There's no one-size-fits ...

Patients with rheumatoid arthritis are treated with drugs that suppress the immune system.